Germany Leads The Global Medical Cannabis Explosion

The entire cannabis community is abuzz with German legalization. Not only is this a massive windfall for cannabis producers around the world with access to markets in the European Union, but it’s also a regulatory call-to-order for every other country that has resisted adopting a more up-to-date approach to medical cannabis access. 

Already, countries like France, Spain and Czechia are racing toward a more balanced approach to medical cannabis access. I expect additional countries to make announcements this year as well. The global medical cannabis explosion is imminent, and money is moving toward the EU and international markets.

Cannabis Industry Developments Within Germany 

If you’re a player in the German cannabis industry, you are likely having sleepless nights with all the action. Reports from all the top groups indicate a massive influx of scripts and patient demand, as well as increased corporate demand for everything from flower to extracts. 

German Cannabis Company Growth

We can watch as cannabis companies in Germany navigate the massive increase in consumer demand. Here are notable German market movements:

• Germany’s largest compounding pharmacy, Gruenhorn, is showing dramatic increases in demand. 

• Notable brand and clinic Canify is reportedly stocking up on more products. 

• Large clinic and marketplace Bloomwell is signaling on social media that they are receiving more patients. 

• Large flower distributors like Cansativa are being flooded with flower requests. 

No matter where you look in Germany, the markets are surging.

Significant Opportunities For Global Cannabis Investors

Investors are back and bringing massive capital into European and global markets. 

Cannabis Funds Prepare For An Influx Of Investments

One of the largest cannabis funds, Artemis Fund Managers, alongside Tenacious Labs, announced the creation of “Europe’s Largest Cannabis Investment Platform” after Germany passed its cannabis reform.